Granted Patent
B2
US 10,807,985 · App. 15/973,378 · Granted Oct 20, 2020
Compositions useful for treating disorders related to kit
Assignee:
Blueprint Medicines Corporation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds and compositions useful for treating disorders related to mutant KIT are described herein.
Claims (1)
1. A compound, wherein the compound is:
Assignments (6)
RELEASE OF SECURITY INTEREST (REEL/FRAME NUMBER 060616/0923)
Recorded Jul 23, 2025
From: TAO TALENTS, LLC
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 072193/0847 →
RELEASE OF SECURITY INTEREST
Recorded Jul 21, 2025
From: PROTOZOA INVESTMENTS, L.P.
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 071777/0840 →
SECURITY INTEREST
Recorded Jul 8, 2022
From: BLUEPRINT MEDICINES CORPORATION
To: GARNICH ADJACENT INVESTMENTS S.A.R.L.
Reel/Frame 060465/0357 →
SECURITY INTEREST
Recorded Jul 8, 2022
From: BLUEPRINT MEDICINES CORPORATION
To: TAO TALENTS, LLC
Reel/Frame 060616/0923 →
ASSIGNEE CHANGE OF ADDRESS
Recorded Jul 6, 2018
From: BLUEPRINT MEDICINES CORPORATION
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 046495/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 7, 2018
From: HODOUS, BRIAN L.; KIM, JOSEPH L.; WILSON, KEVIN J.; WILSON, DOUGLAS; ZHANG, YULIAN
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 045736/0366 →
Continuity (6)
Provisional Application
61975229
· Apr 4, 2014
Provisional Application
61931204
· Jan 24, 2014
Provisional Application
61892086
· Oct 17, 2013
Cited By (3)